Yavuz Sadan, Kasap Murat, Akpinar Gurler, Ozbudak Ersan, Ural Dilek, Berki Turan
Department of Cardiovascular Surgery, Kocaeli University Medical School, Kocaeli, Turkey.
Department of Medical Biology, DEKART Proteomics Laboratory, Kocaeli University Medical School, Umuttepe, 41380 Kocaeli, Turkey.
Biomed Res Int. 2014;2014:942718. doi: 10.1155/2014/942718. Epub 2014 Apr 2.
Pericardial fluid (PF) is often considered to be reflection of the serum by which information regarding the physiological status of the heart can be obtained. Some local and systemic disorders may perturb the balance between synthesis and discharge of PF and may cause its aberrant accumulation in the pericardial cavity as pericardial effusion (PE). PE may then lead to an increased intrapericardial pressure from which the heart function is undesirably affected. For some cases, the causes for the perturbance of fluid balance are well understood, but in some other cases, they are not apparent. It may, thus, be helpful to understand the molecular mechanisms behind this troublesome condition to elucidate a clinical approach for therapeutic uses. In this study, protein profiles of PEs from idiopathic pericarditis patients were analyzed. Control samples from patients undergoing elective cardiac surgery (ECS) were included for comparison. In addition to high abundant serum-originated proteins that may not hold significance for understanding the molecular mechanisms behind this disease, omentin-1 was identified and its level was higher for more than two-fold in PE of IP patients. Increased levels of omentin-1 in PE may open a way for understanding the molecular mechanisms behind idiopathic pericarditis (IP).
心包积液(PF)通常被认为是血清的反映,通过它可以获取有关心脏生理状态的信息。一些局部和全身性疾病可能会扰乱PF合成与排出之间的平衡,并可能导致其在心包腔内异常积聚,形成心包积液(PE)。PE继而可能导致心包内压力升高,从而对心脏功能产生不良影响。对于某些病例,液体平衡紊乱的原因已得到充分了解,但在其他一些病例中,原因并不明显。因此,了解这种棘手病症背后的分子机制可能有助于阐明一种临床治疗方法。在本研究中,分析了特发性心包炎患者心包积液的蛋白质谱。纳入了接受择期心脏手术(ECS)患者的对照样本进行比较。除了可能对理解该疾病背后的分子机制没有意义的高丰度血清源性蛋白质外,还鉴定出了网膜素-1,并且在特发性心包炎患者的心包积液中其水平高出两倍多。心包积液中网膜素-1水平的升高可能为理解特发性心包炎(IP)背后的分子机制开辟一条道路。